SCHEMBL25774349

SCHEMBL25774349

Cc1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-c4ccc(C#N)c(-c5cccc(-c6nc(-c7ccccc7)nc(-c7ccc(C)c(C)c7)n6)c5)c4)c3)n2)cc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 5/20 0.44
▸ CYP1A2 P05177 3/20 0.40
▸ CYP2C9 P11712 3/20 0.40
▸ CYP2C19 P33261 3/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ CYP11B1 P15538 1/20 0.39
▸ CYP11B2 P19099 1/20 0.39
▸ GABRA1 P14867 2/20 0.39
▸ GABRG2 P18507 2/20 0.39
▸ GABRB3 P28472 2/20 0.39
▸ GABRA2 P47869 2/20 0.39
▸ AR P10275 1/20 0.39
▸ GABRA5 P31644 1/20 0.38
▸ GABRA3 P34903 1/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ ALDH1A1 P00352 5/20 0.38
▸ LMNA P02545 2/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ HTT P42858 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25774347 0.91 CYP11B1 (0.46) ABCG2CYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL25775108 0.91 CYP11B1 (0.46) ABCG2CYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL26275874 0.90 GABRG2 (0.41) ABCG2CYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL26553199 0.88 CYP11B1 (0.46) ABCG2CYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL25775099 0.88 CYP11B1 (0.46) ABCG2CYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL26553201 0.85 CYP11B1 (0.42) ABCG2CYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL26017273 0.85 ALDH1A1 (0.49) CYP1A2CYP2C9CYP2C19NPSR1CYP11B1
SCHEMBL26553102 0.84 PRKACA (0.45) ABCG2CYP1A2CYP2C9CYP11B1CYP11B2
SCHEMBL26274337 0.84 ABCG2 (0.44) ABCG2CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL25775148 0.84 CYP11B1 (0.43) ABCG2CYP1A2CYP2C9CYP2C19NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331704-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2023-10-19 — — US disclosed
US-20230331704-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2023-10-19 — — US disclosed
EP-4206195-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME Lg Chem, Ltd. (KR) 2023-07-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230331704-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME NR2E3, NR2E1, NR0B2 ABCG2 3682/4885CYP1A2 91/4885CYP2C9 722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback